PLUS THERAPEUTICS
Plus Therapeutics is dedicated to developing and delivering innovative cell-based therapies to improve the quality and length of life. It is a global, public company engaged in the development and commercialization of stem and regenerative cell therapies for the treatment of cardiovascular disease, reconstructive surgery, and other serious, chronic, and life-threatening conditions. Plus Therapeutics pipeline of candidate drug products includes their lead drug product candidates, RNL and DocePLUS, which are being developed in the U.S. by a dedicated and energetic team of biologists, chemists, engineers, physicians, and other professionals.
PLUS THERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Founded:
1996-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.plustherapeutics.com
Total Employee:
11+
Status:
Active
Contact:
737.255.7194
Email Addresses:
[email protected]
Total Funding:
142.75 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Google Universal Analytics Font Awesome
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-02-15 | Azaya Therapeutics | Azaya Therapeutics acquired by Plus Therapeutics | N/A |
Investors List
Cancer Prevention and Research Institute of Texas
Cancer Prevention and Research Institute of Texas investment in Grant - Plus Therapeutics
GE Capital
GE Capital investment in Post-IPO Debt - Plus Therapeutics
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Debt - Plus Therapeutics
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Debt - Plus Therapeutics
Official Site Inspections
http://www.plustherapeutics.com Semrush global rank: 5.5 M Semrush visits lastest month: 1.55 K
- Host name: cloudproxy10076.sucuri.net
- IP address: 192.124.249.76
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
